1. Home
  2. PGEN vs LWLG Comparison

PGEN vs LWLG Comparison

Compare PGEN & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • LWLG
  • Stock Information
  • Founded
  • PGEN 1998
  • LWLG 1991
  • Country
  • PGEN United States
  • LWLG United States
  • Employees
  • PGEN N/A
  • LWLG N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • LWLG Containers/Packaging
  • Sector
  • PGEN Health Care
  • LWLG Industrials
  • Exchange
  • PGEN Nasdaq
  • LWLG Nasdaq
  • Market Cap
  • PGEN 493.0M
  • LWLG 423.3M
  • IPO Year
  • PGEN N/A
  • LWLG N/A
  • Fundamental
  • Price
  • PGEN $4.14
  • LWLG $3.07
  • Analyst Decision
  • PGEN Buy
  • LWLG
  • Analyst Count
  • PGEN 5
  • LWLG 0
  • Target Price
  • PGEN $7.50
  • LWLG N/A
  • AVG Volume (30 Days)
  • PGEN 18.8M
  • LWLG 2.5M
  • Earning Date
  • PGEN 08-12-2025
  • LWLG 08-14-2025
  • Dividend Yield
  • PGEN N/A
  • LWLG N/A
  • EPS Growth
  • PGEN N/A
  • LWLG N/A
  • EPS
  • PGEN N/A
  • LWLG N/A
  • Revenue
  • PGEN $4,340,000.00
  • LWLG $94,355.00
  • Revenue This Year
  • PGEN $253.63
  • LWLG N/A
  • Revenue Next Year
  • PGEN $699.64
  • LWLG N/A
  • P/E Ratio
  • PGEN N/A
  • LWLG N/A
  • Revenue Growth
  • PGEN N/A
  • LWLG 4.52
  • 52 Week Low
  • PGEN $0.65
  • LWLG $0.79
  • 52 Week High
  • PGEN $5.23
  • LWLG $4.23
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 64.19
  • LWLG 57.68
  • Support Level
  • PGEN $3.89
  • LWLG $2.89
  • Resistance Level
  • PGEN $5.23
  • LWLG $3.50
  • Average True Range (ATR)
  • PGEN 0.36
  • LWLG 0.42
  • MACD
  • PGEN -0.09
  • LWLG -0.03
  • Stochastic Oscillator
  • PGEN 32.30
  • LWLG 55.09

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

Share on Social Networks: